Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.

Clayton P, Chatelain P, Tatò L, Yoo HW, Ambler GR, Belgorosky A, Quinteiro S, Deal C, Stevens A, Raelson J, Croteau P, Destenaves B, Olivier C.

Eur J Endocrinol. 2013 Jul 29;169(3):277-89. doi: 10.1530/EJE-13-0069. Print 2013 Sep.

PMID:
23761422
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.

Stevens A, Clayton P, Tatò L, Yoo HW, Rodriguez-Arnao MD, Skorodok J, Ambler GR, Zignani M, Zieschang J, Della Corte G, Destenaves B, Champigneulle A, Raelson J, Chatelain P.

Pharmacogenomics J. 2014 Feb;14(1):54-62. doi: 10.1038/tpj.2013.14. Epub 2013 Apr 9.

PMID:
23567489
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.

Baş F, Darendeliler F, Aycan Z, Çetinkaya E, Berberoğlu M, Sıklar Z, Öcal G, Timirci Ö, Çetinkaya S, Darcan Ş, Gökşen Şimşek D, Bideci A, Cinaz P, Böber E, Demir K, Bereket A, Turan S, Atabek ME, Tütüncüler F, Isbir T, Bozkurt N, Kabataş Eryılmaz S, Uzunhan O, Küçükemre Aydın B, Bundak R.

Horm Res Paediatr. 2012;77(2):85-93. doi: 10.1159/000335172. Epub 2012 Mar 23.

PMID:
22456308
[PubMed - indexed for MEDLINE]
4.

A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatment.

Whatmore AJ, Patel L, Clayton PE.

Clin Endocrinol (Oxf). 2009 Mar;70(3):429-34. doi: 10.1111/j.1365-2265.2008.03477.x. Epub 2008 Nov 8.

PMID:
19018778
[PubMed - indexed for MEDLINE]
5.

Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.

Ranke MB, Lindberg A, Brosz M, Kaspers S, Loftus J, Wollmann H, Kołtowska-Haggstrom M, Roelants M.

Horm Res Paediatr. 2012;78(1):8-17. doi: 10.1159/000339468. Epub 2012 Jul 24.

PMID:
22832697
[PubMed - indexed for MEDLINE]
6.

The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.

Braz AF, Costalonga EF, Montenegro LR, Trarbach EB, Antonini SR, Malaquias AC, Ramos ES, Mendonca BB, Arnhold IJ, Jorge AA.

J Clin Endocrinol Metab. 2012 Apr;97(4):E671-7. doi: 10.1210/jc.2011-2521. Epub 2012 Jan 25.

PMID:
22278433
[PubMed - indexed for MEDLINE]
7.

Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.

Kaspers S, Ranke MB, Han D, Loftus J, Wollmann H, Lindberg A, Roelants M, Kleintjens J.

Appl Health Econ Health Policy. 2013 Jun;11(3):237-49. doi: 10.1007/s40258-013-0030-4.

PMID:
23649890
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

An observational study of the effectiveness and safety of growth hormone (Humatrope(®)) treatment in Japanese children with growth hormone deficiency or Turner syndrome.

Tai S, Tanaka T, Hasegawa T, Ozono K, Tanaka H, Kanzaki S, Yokoya S, Fujieda K, Chihara K, Seino Y.

Endocr J. 2013;60(1):57-64. Epub 2012 Oct 20.

PMID:
23001148
[PubMed - indexed for MEDLINE]
Free Article
9.

GHR and VDR genes do not contribute to the growth hormone (GH) response in GH deficient and Turner syndrome patients.

Alvarez-Nava F, Marcano H, Pardo T, Paoli M, Gunczler P, Soto M, Villaloboss J, Lanes R.

J Pediatr Endocrinol Metab. 2010 Aug;23(8):773-82.

PMID:
21073120
[PubMed - indexed for MEDLINE]
10.

Impact of age and duration of growth hormone therapy in children with Turner syndrome.

Ross J, Lee PA, Gut R, Germak J.

Horm Res Paediatr. 2011;76(6):392-9. doi: 10.1159/000333073. Epub 2011 Nov 29.

PMID:
22156541
[PubMed - indexed for MEDLINE]
11.

Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.

Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, Wales JK, Clayton PE.

Clin Endocrinol (Oxf). 2000 Sep;53(3):329-36.

PMID:
10971450
[PubMed - indexed for MEDLINE]
12.

Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.

Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.

Horm Res. 2009;71(3):167-72. doi: 10.1159/000197874. Epub 2009 Feb 3.

PMID:
19188742
[PubMed - indexed for MEDLINE]
13.

Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.

Wan L, Chen WC, Tsai Y, Kao YT, Hsieh YY, Lee CC, Tsai CH, Chen CP, Tsai FJ.

Pediatr Res. 2007 Dec;62(6):735-40.

PMID:
17957148
[PubMed - indexed for MEDLINE]
14.
16.

Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.

Jorge AA, Arnhold IJ.

Horm Res. 2009 Apr;71 Suppl 2:55-63. doi: 10.1159/000192438. Epub 2009 Apr 29. Review.

PMID:
19407498
[PubMed - indexed for MEDLINE]
17.

Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.

Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ.

J Clin Endocrinol Metab. 2006 Mar;91(3):1076-80. Epub 2005 Nov 15.

PMID:
16291702
[PubMed - indexed for MEDLINE]
18.

Adult height after growth hormone treatment in Japanese children with idiopathic growth hormone deficiency: analysis from the KIGS Japan database.

Fujieda K, Tanaka T, Takano K, Chihara K, Seino Y, Irie M; KIGS Japan Scientific Committee.

J Pediatr Endocrinol Metab. 2011;24(7-8):457-62.

PMID:
21932582
[PubMed - indexed for MEDLINE]
19.

Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.

Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG.

J Clin Endocrinol Metab. 2008 Feb;93(2):352-7. Epub 2007 Nov 13.

PMID:
18000092
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk